Adding The KIT Inhibitor Dasatinib (DAS) To Standard Induction and Consolidation Therapy For Newly Diagnosed Patients (pts) With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Initial Results Of The CALGB 10801 (Alliance) Study
- Citation:
- Blood vol 122 (21) Abstract 357
- Meeting Instance:
- ASH 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2913
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Guido Marcucci Susan Geyer John Zhao Andrew J Caroll Donna Bucci Ravi Vij William Blum Timothy Pardee Meir Wetzler Wendy Stock Clara D. Bloomfield Richard A. Larson Richard M. Stone
- Networks:
- Study
- CALGB-10801
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: